Dapefy SM 10/100/1000 Tablets 28’s is an advanced triple‑combination diabetes medication formulated to provide comprehensive blood sugar management for adults with Type 2 Diabetes Mellitus. Each tablet contains: Dapagliflozin 10mg – an SGLT2 inhibitor that reduces glucose reabsorption in the kidneys, helping the body eliminate excess sugar through urine. Sitagliptin 100mg – a DPP‑4 inhibitor that increases incretin hormone levels, improving insulin release after meals and reducing glucose production in the liver. Metformin 1000mg – a first‑line biguanide that decreases hepatic glucose production and improves insulin sensitivity, helping the body utilize glucose more effectively. This triple‑strength formulation provides synergistic action to improve glycemic control, especially in patients whose blood sugar levels remain elevated despite monotherapy or dual therapy. Dapefy SM helps: Lower fasting and post‑meal blood glucose Improve insulin responsiveness Enhance glucose excretion via urine Reduce HbA1c levels Support long‑term metabolic control The medication is typically taken once daily with meals and should be used under strict medical supervision due to the potency of combined agents. Dapefy SM is especially beneficial for adults requiring intensive glucose management or those with difficulty achieving target glucose levels using fewer medications.
